The impact of a programme to improve quality of care for people with type 2 diabetes on hard to reach groups: The GEDAPS study

Danielle H. Bodicoat, Xavier Mundet, Melanie J. Davies, Kamlesh Khunti, Pilar Roura, Josep Franch, Manel Mata-Cases, Xavier Cos, J. Franciso Cano

    Research output: Contribution to journalArticleResearchpeer-review

    8 Citations (Scopus)

    Abstract

    © 2014 Primary Care Diabetes Europe. Aims We investigated whether a continuous quality improvement programme in primary care for people with type 2 diabetes led to better care and outcomes in hard to reach groups. Methods GEDAPS was implemented in Catalonia, Spain between 1993 (n = 2239) and 2002 (n = 5819). Process (e.g. education), intermediate (e.g. HbA1c) and final (e.g. retinopathy) outcomes were compared between urban and rural areas, and between younger (74 years) and older (75 years) individuals as examples of harder to reach groups. Results In 1993, people in urban areas had significantly better or similar outcomes to rural areas; by 2002, most outcomes improved in urban and rural areas. For all outcomes, the improvement in rural areas was similar to or better than urban areas. Similarly, for most outcomes, the younger and older group improved, with the older group experiencing similar or better improvements than the younger group for all indicators, except coronary artery disease. Conclusions A quality improvement programme was associated with equivalent or better outcomes in hard to reach groups, regardless of whether they were specifically targeted. The ability to apply one programme to all populations could save time and money.
    Original languageEnglish
    Pages (from-to)211-218
    JournalPrimary Care Diabetes
    Volume9
    Issue number3
    DOIs
    Publication statusPublished - 1 Jun 2015

    Keywords

    • Quality improvement
    • Quality ofhealthcare
    • Ruralpopulation
    • Type2diabetesmellitus

    Fingerprint

    Dive into the research topics of 'The impact of a programme to improve quality of care for people with type 2 diabetes on hard to reach groups: The GEDAPS study'. Together they form a unique fingerprint.

    Cite this